BioCentury
ARTICLE | Clinical News

VistaGen preclinical data

November 19, 2007 8:00 AM UTC

In rats, systemic administration of AV-101 increased the firing rate and burst firing activity of dopaminergic neurons by 27% and 61%, respectively. In the brain, AV-101 is converted to 7-chlorokynure...